Telehealth Anxiety Prescribing: What Psychiatric NPs Can Do in North Carolina

You spent years training to help people with anxiety disorders. Now you’re staring at an inbox full of patient requests, a waiting list stretching into next quarter, and you’re wondering: Can I actually expand my practice through telehealth? What are the rules for prescribing anxiety meds remotely? And does my prescriptive authority as a PMHNP match what a psychiatrist can do?

Here’s the reality: Yes, both psychiatrists and PMHNPs can prescribe anxiety medications via telehealth in 2026 — but the specifics depend heavily on your license type, your state, and whether you’re prescribing controlled substances like benzodiazepines. The rules have evolved dramatically since COVID, and understanding where we stand now (and where regulations are headed) can mean the difference between building a thriving telepsychiatry practice and hitting compliance roadblocks.

Let’s break down exactly what you can do, state by state, and how to navigate the regulatory landscape without the legal headaches.

Federal Telehealth Rules: The Telemedicine Flexibility Extension Through 2026

The Short Answer: As of February 2026, you can prescribe controlled substances for anxiety via telehealth without an initial in-person visit, thanks to extended COVID-era flexibilities.

The Background: Before the pandemic, the Ryan Haight Act required at least one in-person medical evaluation before a DEA-registered practitioner could prescribe any controlled substance. For anxiety treatment, this meant psychiatrists and PMHNPs couldn’t initiate benzodiazepines (Schedule IV) or certain other medications purely through video visits.

COVID changed everything. The DEA and HHS temporarily suspended this requirement in March 2020, and they’ve been extending it ever since. Most recently, in January 2026, they extended these telemedicine flexibilities through December 31, 2026. This means right now, you can:

• Conduct an initial psychiatric evaluation via secure video
• Prescribe alprazolam (Xanax), lorazepam (Ativan), clonazepam (Klonopin), or other Schedule IV anxiolytics
• Manage follow-up medication adjustments entirely remotely
• Even prescribe Schedule II medications (like stimulants for comorbid ADHD) via telehealth

Why This Matters: In 2024 alone, over 7 million controlled substance prescriptions were written via telemedicine. Cutting off this access would have created a care crisis. The extension gives the DEA time to finalize permanent telemedicine prescribing regulations expected later in 2026.

What’s Coming: The DEA is working on a ‘special telemedicine prescribing registration’ that would allow controlled substance prescribing via telehealth under certain safeguards (likely requiring audio-visual interaction, identification verification, and PDMP checks). Until those rules finalize, the current flexibilities remain in place.

Action Item: Stay alert for DEA’s final rule publication (expected Q3-Q4 2026). You may need to obtain an additional registration or meet new standards, but for now, you’re operating under the temporary extension.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Psychiatrist vs PMHNP Prescribing Authority: Where the Gaps Are

This is where it gets state-specific and occasionally frustrating.

Psychiatrists (MD/DO): The Baseline

If you’re a psychiatrist, you have full, independent prescriptive authority in all 50 states. You can:

• Prescribe any FDA-approved medication for anxiety
• Initiate and manage controlled substances without physician oversight
• Practice via telehealth in any state where you hold a medical license
• Bill Medicare, Medicaid, and commercial insurance at physician fee schedule rates

There are no state-level restrictions on what you can prescribe (only how — following standard of care, PDMP requirements, etc.). Your scope is consistent nationwide.

PMHNPs: It Depends on Your State

Psychiatric Mental Health Nurse Practitioners face a patchwork of regulations. About half of US states grant Full Practice Authority (FPA), meaning you can evaluate, diagnose, and prescribe (including controlled substances) independently. The other half require some form of physician collaboration or supervision.

Full Practice Authority States (Examples):

• New York (since April 2022): PMHNPs practice completely independently — no collaborative agreement needed
• Oregon, Washington, Arizona, Colorado: Long-standing FPA for NPs
• California (transitioning): New ‘103 NP’ and ‘104 NP’ categories allow independence after experience thresholds (fully effective 2026)

In these states, a PMHNP’s prescribing authority for anxiety medications essentially matches a psychiatrist’s. You can prescribe SSRIs, SNRIs, benzodiazepines, buspirone, beta-blockers — the full toolkit.

Reduced/Restricted Practice States (Examples):

Texas: You must maintain a Prescriptive Authority Agreement with a physician. Additionally, Texas limits NP prescribing of Schedule II controlled substances to hospital settings or hospice care. For anxiety treatment, this mainly affects prescribing stimulants for comorbid ADHD. You can prescribe benzodiazepines (Schedule IV) if your collaborating physician authorizes it in your agreement.

Florida: Requires a written protocol with a supervising physician. Florida has a quirky rule: NPs are limited to a 7-day supply of controlled substances unless you’re a psychiatric NP treating a mental health condition — in which case the limit doesn’t apply. So a Florida PMHNP can prescribe a 30-day supply of Xanax for generalized anxiety disorder, but the supervising physician relationship must be in place.

Pennsylvania: Requires a collaborative agreement with a physician who must review a percentage of your charts (100% for Schedule II prescriptions). You cannot practice independently, period. Efforts to pass FPA legislation have stalled multiple times.

Illinois: Has a hybrid model. After 4,000 clinical hours and 250 hours of additional CE, you can apply for Full Practice Authority. However, even with FPA, you need a one-time physician agreement to prescribe benzodiazepines and Schedule II narcotics — essentially a sign-off that these medications are in your scope.

The Bottom Line: If you’re a PMHNP in a restricted state, you need to:

1. Find a collaborating physician (which may cost money)
2. Ensure your practice agreement specifically authorizes anxiety medication management
3. Stay within the boundaries of that agreement for controlled substances
4. Verify your state allows telehealth practice under a collaborative agreement (some states require the collaborating physician to be nearby)

This is where platforms like Klarity Health can help — they handle credentialing across states and can pair PMHNPs with collaborating physicians where required, removing that administrative burden from your plate.

State-by-State Telehealth Prescribing Rules for Anxiety Medications

Let’s get specific. Here’s what you need to know in the priority states:

California

• Psychiatrists: No state restrictions beyond federal rules. Prescribe freely via telehealth.
• PMHNPs: Historically required physician-supervised standardized procedures. New as of 2023-2026: AB 890 created pathways for experienced NPs to practice independently. ‘103 NPs’ (in group settings) started in 2023; ‘104 NPs’ (full solo practice) applications open in 2026. Until you achieve 104 status, you need protocols.
• Telehealth Notes: California has payment parity (AB 744) — insurers must reimburse telehealth at the same rate as in-person. No special controlled substance barriers for telehealth prescribing.

Texas

• Psychiatrists: Independent. Can prescribe all anxiety meds via telehealth.
• PMHNPs: Must have Prescriptive Authority Agreement. Cannot prescribe Schedule II outside hospital/hospice settings. Benzodiazepines (Schedule IV) are allowed if in your agreement.
• Telehealth Notes: Texas bans telemedicine treatment of chronic pain with controlled substances, but this doesn’t apply to anxiety disorders. Must check Texas PMP (PDMP) before prescribing controlled meds. Texas has no state-mandated payment parity for telehealth, but many insurers voluntarily pay equivalently.

Florida

• Psychiatrists: Independent. Can prescribe Schedule II via telehealth if treating a psychiatric disorder (Florida statute carves this out specifically).
• PMHNPs: Require physician protocol. 7-day limit on controlled substances except for psychiatric NPs treating mental illness (then no limit). Can prescribe benzodiazepines and appropriate anxiety medications under protocol.
• Telehealth Notes: Florida bans telehealth prescribing of Schedule II except for psychiatric treatment, making it permissible for anxiety with comorbid ADHD. Must use Florida’s PDMP (E-FORCSE). Out-of-state telehealth registration exists but prohibits controlled substance prescribing without full FL licensure.

New York

• Psychiatrists: Independent, full authority.
• PMHNPs: Full Practice Authority since April 2022. No collaborative agreement needed. You can prescribe all anxiety medications independently.
• Telehealth Notes: Strong payment parity laws. Must check iSTOP PDMP for every controlled substance prescription (one of the strictest PDMP mandates nationally). Otherwise, telehealth prescribing aligns with in-person rules.

Pennsylvania

• Psychiatrists: Independent.
• PMHNPs: Collaborative agreement required (can supervise max 4 NPs). Physician must review 10% of charts minimum, 100% of Schedule II prescriptions within 24 hours.
• Telehealth Notes: No comprehensive state telehealth statute, but practice follows federal guidelines. Medicaid and most commercial insurers cover tele-mental health. Physician collaboration requirement makes pure-telehealth NP practice logistically harder without organizational support.

Illinois

• Psychiatrists: Independent.
• PMHNPs: Start with collaborative agreement required. After 4,000 hours + 250 CE hours, can apply for FPA. Even with FPA, need physician consultation agreement for benzodiazepines and Schedule II.
• Telehealth Notes: Strong insurance parity (2021 law). Must check Illinois PMP before controlled substance prescribing and every 90 days thereafter. Telehealth expansion ongoing to address workforce shortages (ratio of 1:5,849 patients per psychiatrist statewide).

What About Reimbursement? The Economics of Telehealth Anxiety Treatment

Here’s a reality check: you can prescribe all the right medications, but if reimbursement doesn’t support your practice model, it won’t be sustainable.

Medicare Rates (2026)

Medicare pays psychiatrists well for medication management:

• 90792 (Initial psychiatric evaluation with medication): ~$202
• 99213 (15-minute established patient med check): ~$95
• 99214 (25-minute moderate complexity): ~$136
• 90833 (30-minute therapy add-on): ~$81

Telehealth visits are currently paid at the same rate as in-person through at least late 2024, with extensions likely through September 2025 and potentially beyond.

Medicare Caveat: There was a proposed rule requiring Medicare patients to have an in-person visit within 6 months for tele-mental health services. Enforcement has been repeatedly delayed. As of February 2026, you can still provide ongoing telehealth medication management to Medicare patients without periodic in-person visits, but monitor for rule changes.

Medicaid Rates

Medicaid pays roughly 50-60% of Medicare rates:

• 90792: ~$85 (vs $202 Medicare)
• 99213: ~$40-50 (vs $95 Medicare)

The per-visit rate is lower, but Medicaid volume is high — many patients with anxiety disorders are Medicaid beneficiaries. Most states now permanently cover telehealth for mental health at parity with in-person rates.

Commercial Insurance

Private payers typically pay 100-150% of Medicare rates. Many states now require payment parity for telehealth mental health services. Examples:

• California (AB 744): Parity required
• Illinois: Parity required
• New York: Parity required
• Texas: No state parity law, but most major insurers pay equally

NP Reimbursement Difference

PMHNPs billing under their own NPI receive 85% of the physician fee schedule from Medicare. Some private insurers also pay at slightly reduced rates. This doesn’t mean PMHNPs earn 85% of what psychiatrists earn — overhead differences, salary structures, and volume often balance out — but it’s a factor platforms and practices account for in their economics.

The Real Economics of Patient Acquisition: Why Klarity Makes Sense

Let’s talk about what nobody wants to admit: getting qualified patients to your virtual door is expensive and time-consuming.

The DIY Marketing Reality

If you’re thinking, ‘I’ll just build my own telehealth practice and market it myself,’ here’s what you’re actually signing up for:

SEO (Search Engine Optimization):

• Timeline: 6-12 months before meaningful patient flow
• Cost: $2,000-5,000/month for a decent agency, plus your website development
• Reality: You’re competing with Psychology Today, BetterHelp, local hospital systems, and hundreds of other providers
• Expertise required: Keyword research, content creation, technical optimization, backlink building

Google Ads (PPC):

• Cost per click for mental health keywords: $15-40+
• Conversion rate: 2-5% (most clicks don’t become patients)
• Realistic cost per booked patient: $200-400+ after factoring in no-shows and qualification
• Requires: Ongoing optimization, A/B testing, landing page development, staff to handle and qualify leads

Directory Listings:

• Psychology Today: Monthly subscription + you’re competing with 500 other providers on the same search page
• Zocdoc: $35-100+ per booking plus monthly platform fees
• Result: Some patient flow, but you’re still paying for every lead and handling all the screening

Total Monthly Marketing Investment (realistic):

• Agency/consultant fees: $2,000-4,000
• Ad spend: $1,000-2,000
• Directory subscriptions: $200-500
• Staff time to handle inquiries and no-shows: $500-1,000
• Total: $3,700-7,500/month with no guaranteed ROI

And that’s before you factor in:

• Months of testing before campaigns work
• Failed campaigns that waste budget
• The learning curve if you’re doing it yourself
• Time away from seeing patients

The Klarity Health Model: Pay Only for Qualified Patients

Klarity operates on a pay-per-appointment model. You pay a standard listing fee per new patient lead, and that’s it. No upfront marketing spend. No monthly subscriptions. No wasted ad spend on clicks that don’t convert.

What you get:

• Pre-qualified patients already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients
• Credentialing support across multiple states
• Collaborative agreements handled for PMHNPs in restricted states

The Economic Case:Instead of gambling $3,000-5,000/month on marketing with uncertain results, you pay only when a qualified patient books with you. That’s guaranteed ROI versus gambling on marketing channels.

Could you eventually build a cost-effective DIY marketing system? Sure — if you have the budget, expertise, and patience to invest 6-12 months while learning what works. But for most providers, especially those starting out or scaling, a platform that handles patient acquisition removes the risk entirely.

Controlled Substance Prescribing: PDMP Requirements and Best Practices

Regardless of whether you’re a psychiatrist or PMHNP, prescribing benzodiazepines or other controlled anxiolytics via telehealth requires compliance with state Prescription Drug Monitoring Program (PDMP) laws.

Key Requirements by State:

• Florida: Must check E-FORCSE before prescribing any controlled substance
• Texas: Must check Texas PMP before initial prescription
• New York: Must check iSTOP for every controlled substance prescription (strictest in the nation)
• California, Pennsylvania, Illinois: PDMP check required before initiating and periodically during treatment

Best Practices:

1. Patient Identification: Use government-issued ID verification during initial telehealth visit
2. Document Rationale: Clearly note why a controlled substance is clinically appropriate (versus non-controlled alternatives)
3. Risk Assessment: Screen for substance use history, concurrent prescriptions, and risk factors
4. Informed Consent: Document patient understanding of controlled substance risks, including dependence potential
5. Follow-up Plan: Schedule earlier follow-ups when initiating benzodiazepines (typically 2-4 weeks, not 3 months)

Telehealth-Specific Considerations:

• Ensure your video platform is HIPAA-compliant and has adequate bandwidth for proper assessment
• Document that you performed a visual examination (observing patient’s appearance, behavior, level of distress)
• Some states may require you to note that the encounter was via telehealth in your prescription notes
• Keep records of patient consent for telehealth treatment

FAQ: Provider Questions About Telehealth Anxiety Prescribing

Can I prescribe benzodiazepines to a patient I’ve never met in person?

Yes, through December 2026 under the extended telemedicine flexibilities. After that, follow whatever permanent DEA rules are established. Most states have no additional in-person requirements beyond federal law.

What if my patient is in a different state?

You must be licensed in the state where the patient is physically located at the time of the telehealth visit. You cannot prescribe across state lines without a license in that state. Some states participate in licensure compacts (like IMLC for physicians) to streamline multi-state licensing.

As a PMHNP in a restricted state, can I do telehealth without a local collaborating physician?

It depends. Some states (like Texas) require the collaborating physician to be within a certain distance. Others allow remote collaboration. Check your state’s specific rules. Platforms like Klarity can provide or arrange collaborating physicians in states where required.

Will insurance cover telehealth anxiety medication management?

Yes. Most states now have payment parity laws, and Medicare/Medicaid cover telehealth mental health services. Verify your specific payer contracts, but in general, telehealth is reimbursed equivalently to in-person visits for psychiatric services.

Can I start a patient on an SSRI via telehealth, or do controlled substances have different rules?

SSRIs (like sertraline, escitalopram) are not controlled substances and have no special telehealth restrictions. You can initiate, adjust, and manage them entirely via video visits following standard clinical practice. The telehealth prescribing flexibility extensions specifically address controlled substances (Schedules II-V).

How do I stay compliant with PDMP requirements across multiple states?

You’ll need to register for each state’s PDMP system where you’re licensed and prescribing. Some states have interstate data sharing (PMP InterConnect), which can streamline checks if your patient has a prescription history in another state. Build PDMP checks into your workflow before every controlled substance prescription (or according to state-specific frequency requirements).

What’s the difference between telehealth prescribing as a psychiatrist versus a PMHNP?

Scope: In FPA states, PMHNPs and psychiatrists have equivalent prescribing authority. In restricted states, PMHNPs need physician collaboration/supervision.

Reimbursement: PMHNPs typically receive 85% of physician rates from Medicare (sometimes less from other payers).

Autonomy: Psychiatrists can practice independently anywhere they’re licensed. PMHNPs may need organizational support or collaborating physicians depending on state law.

Are there specific anxiety medications I can’t prescribe via telehealth?

Generally, no — but state-specific rules apply. For example:

• Texas NPs can’t prescribe Schedule II (like stimulants) outside hospital settings
• Florida has quantity limits for some NP prescriptions of controlled substances (with psychiatric treatment exceptions)
• Some states might restrict certain high-risk medications through telehealth (check your state medical board guidance)

For standard anxiety medications (SSRIs, SNRIs, buspirone, beta-blockers, benzodiazepines), telehealth prescribing is widely permissible with proper evaluation.

What happens when the DEA’s temporary rules expire?

The current extension runs through December 31, 2026. The DEA is expected to issue permanent telemedicine prescribing regulations before then. These rules will likely require:

• A special telemedicine registration (in addition to your DEA license)
• Audio-visual interaction for controlled substance prescribing
• Patient identification and verification procedures
• Possible state-by-state variations

Monitor DEA announcements in late 2026 and be prepared to adjust your practice accordingly. The expectation is that some form of telehealth controlled substance prescribing will continue to be allowed — the specifics are what’s being finalized.

Getting Started: Joining a Telehealth Platform vs Building Your Own Practice

You have two paths forward:

Building Your Own Telehealth Practice

Pros:

• Complete autonomy over your schedule and patient selection
• Keep 100% of revenue (minus overhead)
• Build long-term practice equity

Cons:

• Requires significant upfront investment ($5,000-10,000+ for infrastructure)
• Marketing costs $3,000-7,000/month with 6-12 month ramp-up time
• Credentialing across multiple states is time-consuming
• You handle all administrative burden (billing, scheduling, tech support)
• Financial risk if patient acquisition doesn’t work

Best for: Established providers with capital, marketing expertise, and patience

Joining Klarity Health

Pros:

• Zero upfront investment or monthly fees
• Pre-qualified patient flow from day one
• Built-in telehealth infrastructure and credentialing support
• Collaborative agreements handled for PMHNPs where needed
• Pay only when you see patients (guaranteed ROI)
• Both insurance and cash-pay patient options
• Multi-state practice support

Cons:

• Platform takes a percentage (via the listing fee per patient)
• Less autonomy than solo practice
• Patient relationships are somewhat mediated by the platform

Best for: Providers starting out, scaling quickly, or wanting predictable economics without marketing risk

The Reality: Most providers underestimate how hard patient acquisition is. Klarity removes that risk entirely. You can always build your own practice later once you have a stable patient base and can afford to invest in marketing — but starting with a platform that hands you qualified patients lets you focus on what you’re trained to do: treating anxiety disorders.

Final Thoughts: The Opportunity for Anxiety Prescribers in 2026

Here’s what it comes down to:

The demand is massive. Anxiety disorders affect 40+ million adults in the US. Post-pandemic rates are higher than ever. Psychiatrist-to-patient ratios in states like Texas (1:8,966) and Florida (1:8,577) are unsustainable.

The regulations support telehealth. Federal flexibilities are extended through 2026, and most states have permanently embraced tele-mental health with payment parity.

The economics work. Medication management visits are well-reimbursed, especially through Medicare and commercial insurance. Telehealth overhead is minimal.

The barrier is patient acquisition. DIY marketing is expensive, slow, and uncertain. Platforms that pre-qualify patients and handle the infrastructure remove that barrier entirely.

Whether you’re a psychiatrist with full prescribing authority or a PMHNP navigating collaborative agreements, the opportunity to build a sustainable telehealth anxiety practice is real — if you understand the regulations and choose the right business model.

Ready to explore how Klarity Health can help you reach more patients without the marketing headaches? Learn more about joining our provider network and start seeing pre-qualified anxiety patients on your schedule.

Citations and Sources

The following sources were consulted to provide up-to-date, accurate information as of February 26, 2026:

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities through 2026’ (January 2, 2026). Official .gov source confirming federal telehealth prescribing policy extensions. www.hhs.gov

2. Florida Statutes §464.012 and §456.47 – Florida Nurse Practice Act & Telehealth regulations (2024 Statutes). State law defining PMHNP scope and telehealth prescribing rules. www.flsenate.gov | www.flsenate.gov

3. California Board of Registered Nursing – AB 890 Implementation FAQs (Updated 2024). Official state regulatory guidance on new NP independent practice categories (103 NP and 104 NP). rn.ca.gov

4. Nurse Practitioners of New York – ‘NP Modernization Act Passes in NY’ (April 9, 2022). Professional association announcement of New York’s full practice authority legislation. npny.enpnetwork.com

5. Texas Medical Board FAQ – NP Prescribing of Schedule II Drugs Under Physician Delegation (Current as of 2026). Official state board guidance on controlled substance prescribing limitations for NPs. www.tmb.state.tx.us

Source:

• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=Nurse%20practitioners%20,three%20categories%20of%20practice%20authority
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=Illinois%20is%20one%20of%20the,that%20they%20can%20handle%20unsupervised
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,19%20pandemic%20and
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=2025
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20telemedicine%20flexibilities%20were%20first,off%20access%20to%20needed%20medications
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20extension%20gives%20DEA%20and,patient%20safety%20and%20preventing%20misuse
• https://www.flsenate.gov/laws/statutes/2022/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.littlehealthlawblog.com/texas-state-telemedicine-prescribing-rules/#:~:text=C
• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=While%20any%20NP%20with%20prescriptive,Their%20expertise%20includes
• https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes#:~:text=On%20April%209th%2C%20Governor%20Hochul,Practice%20Authority%20for%20NYS%20NPs